Dermatology

Dermatopathology Services at Mount Sinai

Image of researcher in lab

From its inception in 1986, the Dermatopathology Division at The Mount Sinai Hospital has built one of the most advanced services in the region. We deliver timely and accurate interpretation of more than 50,000 specimens a year to Mount Sinai Health System physicians, as well as to dermatologists throughout the tri-state area and beyond, in an efficient and accommodating manner. 

The Mount Sinai Dermatopathology Laboratory is now operating as an independent laboratory within the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai. Dermatopathology services that were previously processed through the main hospital pathology laboratory will now be managed directly by our dedicated dermatopathology team at our new location, 533 West 57th Street, Sixth Floor, Suite B, New York, NY, 10019.
 
Under the leadership of Shane Meehan, MD, Medical Director, and  Robert Phelps, MD, the Dermatopathology Laboratory has acquired vast experience in examining all types of specimens, both common and rare. The Dermatopathology Lab continues to develop and adopt the latest techniques, including artificial intelligence, to deliver the most detailed and accurate interpretation of each specimen.   
 
We are the primary referral source for specimens from Mount Sinai’s dermatologic community, which includes scores of Mount Sinai Health System physicians, as well as dermatologists practicing across New York City.

For second opinion services, please contact Mount Sinai Dermatopathology at dermpathadmin@mountsinai.org or call 646-493-1588.

Melanoma and Skin Cancer Research  
The team at the Dermatopathology Division works closely with the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center to conduct impactful research. Jonathan Ungar, MD, Mark Lebwohl, MD, Patrick Brunner, MD, Nicholas Gulati, MD, PhD, Andrew Ji, MD and Benjamin Ungar, MD are studying the biology of melanoma and skin cancer. They collaborate with the Dermatopathology Division to pursue the latest scientific and therapeutic advances.